Home / Dallah Healthcare Co. / 2023 Annual Results

Dallah Healthcare Co. 2023 Annual Results

Revenue

SAR 2.94B

Net Profit

SAR 385M

EPS

SAR 3.70

Operating Cash Flow

SAR 626M

Dallah Healthcare Co. (4004) reported full year 2023 revenue of SAR 2.94B, up 84.8% from SAR 1.59B in 2022. Net profit came in at SAR 385M, up 40.4% year on year. Earnings per share were SAR 3.70. The company generated SAR 626M in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 1.62 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 1.62.

Key Financial Metrics

Metric	2023	2022
Revenue	SAR 2.94B	SAR 1.59B
Net Profit	SAR 385M	SAR 274M
Gross Profit		SAR 895M
Net Margin	13.1%	17.2%
ROE	12.0%	13.8%
EPS	SAR 3.70
Total Assets	SAR 6.24B	SAR 4.92B
Total Equity	SAR 3.20B	SAR 1.99B
Total Liabilities	SAR 2.77B
Operating Cash Flow	SAR 626M

Year on Year Comparison

Revenue increased by 84.8% compared to 2022. Net profit increased by 40.4%. Both revenue and profit grew — indicating expanding business.

View full company profile →

View all years:

2024 2023 2022 2021 2020 2019

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2024-05-12.